Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan 14;17(3):907-910.
doi: 10.1016/j.radcr.2021.11.049. eCollection 2022 Mar.

Steroid responsive inflammatory myofibroblastic tumor of the lung evaluated by FDG PET/CT imaging

Affiliations
Case Reports

Steroid responsive inflammatory myofibroblastic tumor of the lung evaluated by FDG PET/CT imaging

James Yuheng Jiang et al. Radiol Case Rep. .

Abstract

A 68-year-old gentleman was referred for 18F-FDG PET/CT for a pulmonary mass in the left upper lobe which demonstrated intensely FDG-avid confluent pulmonary consolidation in the left upper lobe (SUVmax 15.1). Histopathologic biopsy of the left upper lobe lung mass was consistent with inflammatory myofibroblastic tumor (IMT). The patient was started on steroid treatment in conjunction with antibiotics. Follow-up FDG PET/CT 3 weeks after commence of treatment showed remarkable response of the IMTs to therapy with much less avid FDG uptake (SUVmax 5.4) and marked improvement in the pulmonary consolidation. Nevertheless, the patient underwent left upper lobe lobectomy due to evidence of persistent cystic disease and malignant potential associated with IMTs. Final histopathology was consistent with IMT with no evidence of malignancy.

Keywords: FDG; PET; inflammatory myofibroblastic tumor; inflammatory pseudotumor.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
(A) Maximal intensity projection (MIP), (B) axial 18F-FDG PET and (C) axial CT of a 68-year-old-gentleman referred for a pulmonary mass in the left upper lobe demonstrates intensely avid confluent pulmonary consolidation in the left upper lobe (SUVmax 15.1) with mild to moderate uptake in left lower paratracheal lymph node (SUVmax 3.6), and in aortopulmonary window lymph nodes.
Fig 2
Fig. 2
(A) MIP, (B) axial 18F-FDG PET, and (C) axial CT 3 weeks after initiation of steroid and antibiotics demonstrates significant metabolic response (SUVmax 5.1) and near complete resolution of consolidative changes with residual cystic changes and bronchiectasis in the left upper lobe. Previously FDG-avid lymph nodes are no longer evident. No new sites of FDG avid disease was demonstrated.
Fig 3
Fig. 3
Axial CT chest 4 weeks later shows complete resolution of consolidation and further improvement in the irregular opacities in the left upper lobe. There is however, residual left upper lobe fibrosis, bronchiectasis and cystic changes.

References

    1. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509–520. - PubMed
    1. Marino-Enrıquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar A, Fletcher C, et al. Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol. 2011;35:135Y144. - PubMed
    1. Palaskar S, Koshti S, Maralingannavar M, Bartake A. Inflammatory myofibroblastic tumor. Contemp Clin Dent. 2011;2(4):274–277. - PMC - PubMed
    1. Sonomura T, Hasegawa S, Takeuchi H, Ishii S, Sato Morio. Inflammatory myofibroblastic tumor of the lung indistinguishable from adenocarcinoma on imaging studies. Clin Nucl Med. 2014;39(8):740–741. - PubMed
    1. Dong A, Wang Y, Dong H, Cheng C, Zuo C, Lu J. Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation. Clin Nucl Med. 2014;39(2):113–121. - PubMed

Publication types

LinkOut - more resources